Key result
PCI of true ACS bifurcations takes longer but does not impact MI size or MACCE.
Why the study?
True bifurcation lesions causing ACS present therapeutic challenges without recommended strategies, and their influence on clinical outcomes after PCI was unclear.
Does the presence of 'true' bifurcation lesions compared to other bifurcation lesions worsen clinical outcomes in patients undergoing PCI for acute coronary syndrome?
Observational (n=256)
No
Does the presence of 'true' bifurcation lesions compared to other bifurcation lesions worsen clinical outcomes in patients undergoing PCI for acute coronary syndrome?
True bifurcation lesions in acute coronary syndrome are associated with longer PCI duration and greater contrast use, but do not independently increase the risk of adverse cardiovascular outcomes compared to other bifurcation lesions.
Answers are grounded in this paper and cite their sources.
True bifurcations prolong PCI without worsening outcomes; leaves open optimal stenting strategies in ACS.
Introduction: Percutaneous coronary interventions (PCI) in bifurcation lesions with more than 50% stenosis of both main and side branch remain challenging. These “true” bifurcation lesions (TBL) causing acute coronary syndrome (ACS) could pose an additional challenge for adequate treatment since there are no recommended strategies. We investigated the influence of the presence of TBLs as culprit lesions for ACS on the clinical outcomes after PCI. Methods: The study was retrospective and conducted in a high-volume university PCI centre. Study included 256 consecutive patients with native coronary artery bifurcation lesions causing an ACS. Patients with ACS caused by stent thrombosis were not included in the study. All patients underwent PCI of the culprit bifurcation lesion and afterwards were treated according to the appropriate guidelines. Results: Most of the bifurcations were located in left anterior descending 152/256 (59.3%), then in circumflex 66/256 (25.9%) and right coronary artery 38/256 (14.8%). The initial clinical presentation was STEMI in 144/256 (56.2%), then NSTEMI 59/256 (23.1%) and unstable angina in 53/256 (20.7%) patients. TBLs were present in 146/256 (57.0%) patients. TBLs were associated with longer PCI procedural time 48±24min vs. 31±28min (p<0.05) and greater contrast volume 177±73 vs. 149±48 ml (p=0.01), but not with larger myocardial infarction in terms of magnitude of troponin I release 47.35±73.73 vs 31.07±38.05 ng/ml (p=0.164) and LVEF 40±13 vs 42±13% (p=0.439), as compared to other bifurcations. The patients were followed for 405±377 days. MACCE (major adverse cardio-cerebral events: death, myocardial infarction, repeated revascularization and stroke) occurred in 55/256 (21.5%) patients. In univariate regression analysis, provisional PCI strategy was associated with fewer MACCE [OR 0.283 (95 % CI 0.089–0.898)]. However, in the multivariate regression analysis, that included recognized predictors of MACCE (diabetes, LVEF, chronic kidney disease, multivessel disease, provisional PCI strategy, use of ticagrelor, TBLs) only the presence of the multi-vessel coronary artery disease remained an independent predictor of MACCE [OR 5.147 (95 % CI 1.859–14.248)]. Conclusions: TBL in acute coronary syndrome are associated with longer PCI duration, but were not associated with larger myocardial infarction and adverse cardiovascular outcomes. The extent of the CAD at presentation is associated with future cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Maksimović et al. (2019) conducted an observational in Acute coronary syndrome (n=256). True bifurcation lesions vs. Other bifurcation lesions was evaluated on Major adverse cardio-cerebral events (MACCE) (OR 1.745, 95% CI 0.747-4.079, p=0.199). True bifurcation lesions in acute coronary syndrome were associated with longer PCI duration but not with increased major adverse cardio-cerebral events.
Synapse has enriched 10 related papers. Consider them for comparative context: